![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Aroa Biosurgery’s Wound Closure Product Cleared by FDA
Aroa Biosurgery’s Wound Closure Product Cleared by FDA
![ClearanceStamp_Orange.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Orange.gif?t=1609798625&width=430)
The FDA has granted 510(k) clearance to Australia’s Aroa Biosurgery for Symphony, a wound closure product.
The product is designed to reduce the time it takes for a wound to close, particularly for patients with seriously impaired healing or complications from other diseases.
The company said it aims to commercially launch Symphony in the U.S. next year.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct